IDEAYA Biosciences

IDYA · NASDAQ

$35.36+$1.55 (+4.58%)TodayMarket closed · Oct 20, 7:30 PM ET

Prev close $33.81

About IDYA

IDEAYA Biosciences, Inc. engages in the research and development of oncology-focused precision medicine. The company is headquartered in South San Francisco, California and currently employs 145 full-time employees. The company went IPO on 2019-05-23. The firm is engaged in the discovery, development, and commercialization of transformative therapies for cancer. Its product candidates focus on synthetic lethality and antibody-drug conjugates (ADCs) for molecularly defined solid tumor indications. Its product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE161 (PARG), IDE275 (Werner Helicase) and IDE705 (Pol Theta Helicase). Darovasertib is a clinical stage, potent and selective small molecule inhibitor of PKC, a protein kinase that functions downstream of the GTPases GNAQ and GNA11. IDE397 is an oral small molecule inhibitor of methionine adenosyl transferase 2a (MAT2A). IDE161 is an oral small molecule poly (ADP-ribose) glycohydrolase (PARG) inhibitor. IDE275 is an oral small molecule inhibitor of the helicase domain of the Werner protein (WRN), a RecQ enzyme involved in the maintenance of genome integrity.

Employees: 145
Headquarters: South San Francisco, California
Listed: May 23, 2019
Sector: Health Care
Industry: Biotechnology
Website: ideayabio.com

Leadership

IDEAYA Biosciences executives
Name	Title	Since	Age
Terry Rosen	—	—	66
Yujiro Hata	—	2015	51
Joshua Bleharski	—	—	50
Andres Briseno	—	—	39
Michael White	—	—	60
Darrin Beaupre	—	—	58
Stuart Dorman	—	—	47
Theodora Ross	—	—	—
M. Garret Hampton	—	—	59
Catherine Mackey	—	—	69
Scott Morrison	—	—	67
Jeffrey Stein	—	—	70
Wendy Yarno	—	—	70

Suppliers and customers

Price correlation is over one year: 1 means the stocks move together, -1 opposite

IDEAYA Biosciences suppliers and customers
Company	Relationship	Country	Correlation
WuXi AppTec Co H	Supplier and customer	CN	0.80
Roche Holding ROG.SW	Supplier and customer	CH	-0.15
Novartis NOVN.SW	Supplier and customer	CH	-0.32
Pfizer PFE	Supplier and customer	US	-0.35
GlaxoSmithKline GSK.L	Supplier and customer	GB	-0.70
Cyteir Therapeutics CYT	Supplier	US	—
Cancer Research UK	Supplier and customer	GB	—
University of Manchester	Supplier and customer	GB	—
Broad Institute, Inc.	Supplier and customer	US	—
University of California San Diego	Supplier and customer	US	—

Similar companies

Companies in the same industry as IDEAYA Biosciences

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.